Keyword: Rentschler Biopharma

Services

Optimal Time-to-Market for Life-Saving Biopharmaceuticals

Rentschler Biopharma SE -

Rentschler Biopharma offers bioprocess development and cGMP manufacturing for high-quality biopharmaceuticals. The company’s strength lies in its extensive experience...

News

Rentschler to Support BioNTech-Pfizer Vaccine

09.10.2020 -

German CDMO Rentschler Biopharma has reached agreement with Pfizer and BioNTech to handle the downstream purification process for the partnership’s mRNA-based COVID-19...

Strategy & Management

Facing Strong Headwinds

14.09.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.

Strategy & Management

Outsourcing Services: from Gene to Patient

19.02.2020 -

Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient...

News

Rentschler Kicks off Expansion at US Facility

29.11.2019 -

Laupheim, Germany-based contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biopharma, is taking the first step in the expansion...

News

Nikolaus F. Rentschler and Frank Mathias Awarded as "EY Entrepreneur of the Year"

29.10.2019 - Rentschler Biopharma’s chairman of the board, Nikolaus F. Rentschler, together with CEO Frank Mathias have received the "EY Entrepreneur of the Year" award 2019 in the category...

Markets & Companies

Driving Innovation and Extending Its Global Reach

28.10.2019 -

Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."

News

Rentschler Biopharma Extends Japanese Pact

09.10.2019 -

German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with...